Navigation Links
AcelRx Pharmaceuticals Hires Roman Skowronski, M.D., Ph.D. as Vice President of Clinical Development
Date:1/8/2009

REDWOOD CITY, Calif., Jan. 8 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today it has hired Dr. Roman Skowronski as Vice President, Clinical Development. In this new position, Dr. Skowronski will be responsible for development and execution of clinical protocols and providing medical input and review of clinical development strategy. He will report to Dr. Pamela Palmer, the company's Chief Medical Officer.

Prior to joining AcelRx Pharmaceuticals, Dr. Skowronski was Director of Clinical Development at ALZA Corporation, a Johnson & Johnson Company. He has also held clinical research and development positions at Alexza Pharmaceuticals and Stanford University School of Medicine.

"We are extremely pleased to have recruited a candidate of Roman's caliber," stated Pamela Palmer, MD, PhD. "He brings a wealth of knowledge and experience in the management of analgesic drug development programs as well as drug-device combination products."

AcelRx Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the treatment of intermittent and acute medical conditions, with an initial emphasis on pain management.


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... ... Participants of this educational webinar will learn the difference ... advantages and disadvantages of ductless, filtered fume hoods, they will also discover appropriate ... will learn from an industry expert about the different types of ducted and ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... VetStem Biopharma ’s CEO and founder, ... PA, PhD in Riordan’s new book "Stem Cell Therapy: A Rising Tide". Dr. Harman ... years. They bonded over an interest in the potential of stem cell therapy and ...
(Date:9/19/2017)... ... September 19, 2017 , ... One ... about to be eliminated, said Lyle Probst, President, CEO and Founder of ... different than other pathogen detection solutions, Probst said, “Sample preparation takes place inside ...
(Date:9/19/2017)... MI (PRWEB) , ... September 19, 2017 , ... ... laboratory, is pleased to announce the recipients of its 2017 Science Student Award. ... exceptional leadership qualities, and involvement with community service defray the costs of obtaining ...
Breaking Biology Technology:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:8/15/2017)... 15 2017   ivWatch LLC , a medical device company ... today announced receipt of its ISO 13485 Certification, the global standard ... Organization for Standardization (ISO®). ... Model 400 Continuous Monitoring device for the early detection of IV ... "This is an important milestone for ...
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ... board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to ... Delta,s biometric ... Sky Club is now integrated into the boarding process to allow ...
Breaking Biology News(10 mins):